Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "SEC"

3685 News Found

India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies
Opinion | May 29, 2026

India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies

From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies


AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
News | May 29, 2026

AbbVie wins FDA nod for DECNUPAZ in rare blood cancer

BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes


Indian scientists develop AI-enabled tech for biomedical diagnostic applications
Medical Device | May 28, 2026

Indian scientists develop AI-enabled tech for biomedical diagnostic applications

The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention


Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge
Medical Device | May 28, 2026

Remidio’s InstaEyeClinic wins first position at Andhra Pradesh MedTech Innovation Challenge

The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient


India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade
Policy | May 28, 2026

India’s healthcare spending triples to Rs 3.85 lakh crore over the last decade

As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly


Morepen Labs posts strong Q4 FY26 net profit
News | May 28, 2026

Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore


Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Biopharma | May 28, 2026

Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD

Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress


Ashish Mukkirwar appointed CFO of Jubilant Pharmova
People | May 27, 2026

Ashish Mukkirwar appointed CFO of Jubilant Pharmova

The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives


Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
News | May 27, 2026

Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz

The company highlighted continued demand strength and pricing resilience despite global disruptions


China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
Drug Approval | May 26, 2026

China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer

The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer